PRMT1 Is a novel regulator of epithelial-mesenchymal-transition in non-small cell lung cancer

37Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Protein arginine methyl transferase 1 (PRMT1) was shown to be up-regulated in cancers and important for cancer cell proliferation. However, the role of PRMT1 in lung cancer progression and metastasis remains incompletely understood. In the present study, we show that PRMT1 is an important regulator of epithelial-mesenchymal transition (EMT), cancer cell migration, and invasion, which are essential processes during cancer progression, and metastasis. Additionally, we have identified Twist1, a basic helix-loop-helix transcription factor and a well-known E-cadherin repressor, as a novel PRMT1 substrate. Taken together, we show that PRMT1 is a novel regulator of EMT and arginine 34 (Arg-34) methylation of Twist1 as a unique "methyl arginine mark" for active E-cadherin repression. Therefore, targeting PRMT1-mediated Twist1 methylation might represent a novel strategy for developing new anti-invasive/anti-metastatic drugs. Moreover, methylated Twist1 (Arg-34), as such, could also emerge as a potential important biomarker for lung cancer.

Cite

CITATION STYLE

APA

Avasarala, S., Van Scoyk, M., Rathinam, M. K. K., Zerayesus, S., Zhao, X., Zhang, W., … Bikkavilli, R. K. (2015). PRMT1 Is a novel regulator of epithelial-mesenchymal-transition in non-small cell lung cancer. Journal of Biological Chemistry, 290(21), 13479–13489. https://doi.org/10.1074/jbc.M114.636050

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free